Skip to main content

Advertisement

Log in

The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β1 and non-selective β1 + β2 adrenergic receptor blockade

  • Original Article
  • Published:
European Journal of Applied Physiology Aims and scope Submit manuscript

Abstract

Purpose

Habitual endurance exercise results in increased erythropoiesis, which is primarily controlled by erythropoietin (EPO), yet studies demonstrating upregulation of EPO via a single bout of endurance exercise have been equivocal. This study compares the acute EPO response to 30 min of high versus 90 min of moderate-intensity endurance exercise and whether that response can be upregulated via selective adrenergic receptor blockade.

Methods

Using a counterbalanced, cross-over design, fifteen participants (age 28 ± 8) completed two bouts of running (30-min, high intensity vs 90-min, moderate intensity) matched for overall training stress. A separate cohort of fourteen participants (age 31 ± 6) completed three bouts of 30-min high-intensity cycling after ingesting the preferential β1-adrenergic receptor (AR) antagonist bisoprolol, the non-preferential β1 + β2 antagonist nadolol or placebo. Venous blood was collected before, during, and after exercise, and serum EPO levels were determined by ELISA.

Results

No detectable EPO response was observed during or after high intensity running, however, in the moderate-intensity trial EPO was significantly elevated at both during-exercise timepoints (+ 6.8% ± 2.3% at 15 min and + 8.7% ± 2.2% at 60 min). No significant change in EPO was observed post-cycling or between the trials involving βAR blockade.

Conclusion

Neither training mode (running or cycling), nor beta-blockade significantly influenced the EPO response to 30 min of high-intensity exercise, however, 90 min of moderate-intensity running elevated EPO during exercise, returning to baseline immediately post-exercise. Identifying the optimal mode, duration and intensity required to evoke an EPO response to exercise may help tailor exercise prescriptions designed to maximize EPO response for both performance and clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

Supporting data are available from the corresponding author upon request.

Code availability

SPSS (IBM, Armonk, NY, USA) versions 25 and 26 (RRID: SCR_002865) was used for all statistical analyses and Prism (GraphPad, San Diego, CA, USA) version 8 (RRID: SCR_002798) was used to create all figures. No custom code was used in this research.

Abbreviations

βAR:

Beta-adrenergic receptor

BMI:

Body mass index

CI:

Confidence Interval

EDTA:

Ethylenediaminetetraacetic acid

EPO:

Erythropoietin

HCT:

Hematocrit

HGB:

Hemoglobin

HIF:

Hypoxia inducible factor

LT:

Lactate threshold

MCH:

Mean corpuscular hemoglobin

MCHC:

Mean corpuscular hemoglobin concentration

MCV:

Mean corpuscular volume

MPV:

Mean platelet volume PLT Platelets

RBC:

Red blood cells

RDW:

Red-cell distribution width

RPE:

Rating of perceived exertion

SAO2 :

Arterial hemoglobin oxygen saturation

SPO2 :

Peripheral capillary oxygen saturation

VO2 :

Volume of oxygen

VO2max:

Maximum rate of oxygen consumption

VO2peak:

Peak rate of oxygen consumption

VCO2 :

Volume of carbon dioxide

VT:

Ventilatory threshold

References

Download references

Acknowledgements

This work was supported by the National Institute of Health (NIH) Grant R21 CA197527-01A1 to R.J. Simpson, American College of Sports Medicine (ACSM) National Aeronautics and Space Administration (NASA) Foundational Research Grant to N. Agha. I would like to thank Rachel (Graff) Levine and Bridgette Rooney for their contribution to data collection and analysis, as well as Justin Reed for experimental design and manuscript review.

Funding

This work was supported by National Institute of Health (NIH) Grant R21 CA197527-01A1 to R.J. Simpson and American College of Sports Medicine (ACSM) National Aeronautics and Space Administration (NASA) Foundational Research Grant to N. Agha.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard J. Simpson.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Participants provided informed consent and study approval was granted by Committee for the Protection of Human Participants (CPHS) at the University of Houston in accordance with the Declaration of Helsinki.

Consent to participate

Prior to testing, instructions outlining the experimental procedures were given and written informed consent to participate was obtained from each participant.

Consent for publication

Written informed consent that the results of this study may be published in a professional and/or scientific journal without mention of their name or personal information was obtained from each participant.

Additional information

Communicated by Philip D Chilibeck.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Azadan, R.J., Agha, N.H., Kunz, H.E. et al. The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β1 and non-selective β1 + β2 adrenergic receptor blockade. Eur J Appl Physiol 121, 1499–1511 (2021). https://doi.org/10.1007/s00421-020-04558-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00421-020-04558-4

Keywords

Navigation